The John H. Weisburger Page

Weisburger joined the American Health Foundation as its President for Research / Director of the Naylor Dana Institute in 1972 until 1987, and has been Emeritus since 1987. He consulted with RJ Reynolds Tobacco in evaluating its Premier heated tobacco cigarette. His ex-wife, Elizabeth Weisburger, was a researcher at the National Cancer Institute.

Weisburger bio / AHF-IFCP
Weisburger JH research / PubMed

Weisburger was Director of the Bioassay Segment of the Carcinogenesis Contract Program Management Group of the National Cancer Institute (NCI) in 1972.

NCI Carcinogenesis Program, 1972 / tobacco document

Ernst L. Wynder, Dietrich Hoffmann, John H. Weisburger and Charles B. Arnold of the AHF participated in the Conference on the Primary Prevention of Cancer: Assessment of Risk Factors and Future Directions, at the American Health Foundation, June 7-8, 1979. Other participants included LaSalle Leffall, E. Cuyler Hammond, and Lawrence Garfinkel of the American Cancer Society; Arthur Upton, Director of the National Cancer Institute; Gio B. Gori and T.C. Tso of the NCI Tobacco Program; Paul D. Stolley and D. Mark Hegsted, food fascists from Harvard University; Henry T. Lynch, a member of the CTR Scientific Advisory Board in 1996; and a contingent from Deutsche Krebshilfe in Germany, which co-sponsored the event.

Conference on Primary Prevention, 1979 / tobacco document

"In April 1980, a group of scientists met with the American Health Foundation Staff and Dr. Vincent DeVita, the Acting Director of the National Cancer Institute, to define preventive oncology and how preventive oncology could best evolve with the National Cancer Program. An additional participant in the afternoon session of the conference was Dr. Joshua Lederberg, President of the Rockefeller University." Charles LeMaistre and Ernst L. Wynder were chairmen. Other participants included Lester Breslow, Arthur Upton, and John Weisburger. (Editorial: Preventive Oncology and the National Cancer Program. Prev Med 1980 Nov;9(6):823-825.)

Preventive Medicine, 1980 / tobacco document

Memorandum for Record: "Meetings w/Dr. Gerald Wogan (MIT) and Dr. John Weisburger (American Health Foundation); August 6, 1987." FH Christopher to Wayne Juchatz (Senior Vice President and Counsel, RJ Reynolds Tobacco, in 1993), Aug. 10, 1987. "Johnny made clear that he has relinquished his position as Vice President of Research at the American Health Foundation. He is still employed as a researcher 80% of his time." "He made clear how much of a role Ernst Wynder has played in producing safe cigarettes (filter - Eastman and Celanese. He thought Wynder would like the product and suggested we visit with him." "He hinted that tobacco money has paid for lots of bricks in their current research facility and that Wynder is friendly with PM executives. He also felt that this would be a chance for tobacco money to pay for more bricks - an expansion - $4-5 million (-$1 million RJRN lab)."

Christopher to Juchatz, 1987 / tobacco document

Weisburger Associates report on meeting between John Weisburger and key professional staff of RJR Tobacco, Aug. 21, 1987, "on comparative toxicological properties of Alpha Product and a reference IRF4.... The toxicological studies aim to provide the evidence needed to underwrite safety claims associated with Alpha Product," which was Premier. The anti-smokers, Weisburger, and the tobacco industry all presume that only chemical carcinogens are relevant to health, not viruses.

Weisburger Associates 1987 / tobacco document

Deposition of A. Wallace Hayes, one of the "key professional staff of RJR," in Arch vs. The American Tobacco Company, et al., Aug. 7, 1997, on the Aug. 21, 1987 meeting with Weisburger. The anti-smoker attorney, Jack Maistros, as always attempts to make the actions of the servile and deferential tobacco industry appear to be sinister and conspiratorial, while ignoring the real conspirators who have been shoving their fraud down America's throat for five decades. [Maistros, who also represented the cities of Cleveland and Atlanta in their lawsuits against firearms manufacturers, died in an automobile accident on Oct. 26, 2001. Less than two months later, his ally Wendell Gauthier of the Castano lawsuits, who also took up firearms litigation, died of liver cancer. Good riddance. -cast]

Hayes deposition, 1997 / tobacco document

Weisburger was a Peer Reviewer for the tobacco industry's Center for Indoor Air Research (CIAR) group in 1994. The AHF's Klaus Brunnemann, Mirjana Djordjevic, Dietrich Hoffmann, and Jennifer Johnting were also reviewers. There were several reviewers each from the Harvard School of Public Health and Johns Hopkins University as well, but the only organization with more representation than the AHF was the US Environmental Protection Agency itself. And, Morton Lippmann, who was the Chairman of the Science Advisory Board of corrupt EPA ETS report, was a member of the Science Advisory Board of CIAR as well.

CIAR 1994, Peer Reviewers pp 17-21 / tobacco document
CIAR, 1994 / Lorillard Tobacco Document UCSF (pdf, 28pp)

<= Back to AHF Trustees

Elizabeth K. Weisburger

"In 1947, Elizabeth earned a Ph.D. in organic chemistry from the University of Cincinnati, where she remained as a postdoctoral associate with Professor Francis Earl Ray. Here she began her carcinogenesis work by synthesizing analogs of a research carcinogen as part of a project funded by the National Cancer Institute (NCI). She was married that same year to fellow graduate student John Hans Weisburger. The following year, they both went to NCI, located in Bethesda Maryland, on postdoctoral fellowships. In 1951 she qualified to become an officer in the Commissioned Corps of the U.S. Public Health Service; her appointment was to the NCI Laboratory of Biochemistry. Ten years later, the Weisburgers were asked to form a research group to test for carcinogenic activity in environmental and industrial compounds. The Weisburgers collaboration lasted until 1974 when they divorced. Elizabeth stayed at NCI, became head of the Laboratory of Carcinogen Metabolism. In 1981, she was appointed assistant director for chemical carcinogenesis in the NCI Division of Cancer Etiology, where she stayed until her retirement in 1988." (Elizabeth Amy Kreiser Weisburger. Journal of Chemical Education website.)

Elizabeth Weisburger bio / Journal of Chemical Education online
Weisburger EK / PubMed

"NCI began animal testing of chemicals for carcinogenicity in 1961. Elizabeth Weisburger, one of NCI's charter researchers, described the aims of the project: 'There was no mention of a program for large-scale bioassay of industrial or environmental materials. To quote, 'first priority should be given to chemicals most likely to make a contribution to our knowledge of the etiology of cancer and deepen our understanding of their mode of action.''" The number of chemicals under study rose from 40 in 1970 to 200 in 1972, after passage of the National Cancer Act of 1971. (Identifying and Regulating Carcinogens. OTA Background Paper, Nov. 1987.)

OTA, 1987 / Princeton University (pdf, 23pp)

Elizabet Weisburger was a participant in the NIH Workshop on Chemoprevention of Cancer, Feb. 2 and 3, 1978. Other participants included the AHF's longtime research director, her ex-husband John H. Weisburger; future AHF trustees Arthur C. Upton and Jerome J. DeCosse; and Roswell K. Boutwell of the University of Wisconsin, later a member of the Council for Tobacco Research.

NIH Workshop on Chemoprevention of Cancer, 1978 / tobacco document

August 19, 1985 letter from Carol J. Henry (co-signed by Kouri) to Elizabeth K. Weisburger, Assistant Editor-in-Chief of the Journal of the National Cancer Institute, disclosing that the report had been published verbatim in book form by the CTR. It is written on the letterhead of ICF Incorporated, which in 1988 began its involvement as the pass-through for Kenneth G. Brown to write key chapters of the EPA's ETS report.

Henry to Weisburger, 1985 / tobacco document

RJR Interoffice Correspondence from Johnnie R. Hayes to A. Wallace Hayes, May 8, 1989, "Premier Comments at AICR Meeting." "The subject of the withdrawal of PREMIER from the market came up during an informal discussion. Several of the panel members expressed regret that PREMIER had been withdrawn from the market. A few of the panel members stated that they believed R.J. Reynolds had done the 'right thing' in attempting to market the cigarette... As might be expected, most of the comments were prefaced with 'don't quote me, but...' I had the opportunity to discuss several aspects of our programs with Dr. Elizabeth Weisburger, who recently retired from the National Cancer Institute. She attended our Gradient presentation in Washington. She stated that she thought the presentations had been excellent and she appreciated our candor and the detail with which we presented the data. She stated that she had told Richard Adamson, Director of the Division of Cancer Etiology at the NCI, that he should not send a letter to Frank Young in support of FDA regulation of PREMIER. Apparently, he did not take our advice. Again, she did not want to be quoted." [And why did all these people fear to speak to speak their minds? Because of retaliation by ANTI-SMOKER VERMIN, that's why.]

J Hayes to AW Hayes, 1989 / tobacco document

Deposition of A. Wallace Hayes, one of the "key professional staff of RJR," in Arch vs. The American Tobacco Company, et al., Aug. 7, 1997, on the Aug. 21, 1987 meeting with Weisburger. Hayes describes John Weisburger's regard in the scientific community as "Second only in that area to his wife."

Hayes deposition, p. 414, 1997 / tobacco document

Weisburger is a consultant at Mandava Associates, whose stable includes Gary Flamm, former Director of Toxicology at the FDA.

Weisburger / Mandava Associates

cast 03-04-12